Medicare Enrolled
Dr. Parin Patel, DO
Urology Physician · Champaign, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Parin Patel is an urology physician in Champaign, IL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 1,879 Medicare services across 1,539 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $9,120 from 38 pharmaceutical and/or device companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 45% volume in IL
$9,120 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,879
Medicare services
Top 45% in IL for urology physician
1,539
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~157 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
323 | $87 | $252 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
221 | $8 | $32 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
200 | $112 | $397 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
183 | $62 | $171 |
| PSA test (prostate cancer screening) | 172 | $18 | $172 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
134 | $4 | $40 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
123 | $8 | $82 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
120 | $175 | $803 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
79 | $7 | $92 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
54 | $8 | $95 |
| Injection, garamycin, gentamicin, up to 80 mg | 48 | $2 | $16 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
40 | $100 | $1,490 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
38 | $8 | $67 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
31 | $6 | $344 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
28 | $19 | $311 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
27 | $87 | $258 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
22 | $176 | $786 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
21 | $335 | $4,515 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
15 | $247 | $1,320 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.9% high complexity
11.5% medium
86.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,120
Total received (2018-2024)
Avg $1,303/year across 7 years
Top 19% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
197
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,083 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,279
2023
$857
2022
$715
2021
$819
2020
$116
2019
$52
2018
$5,282
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$186
Ferring Pharmaceuticals Inc.
$157
Becton, Dickinson and Company
$150
Astellas Pharma US Inc
$108
Sumitomo Pharma America, Inc.
$90
Endo USA, Inc.
$74
Dendreon Pharmaceuticals LLC
$68
Boston Scientific Corporation
$56
ABBVIE INC.
$53
Merck Sharp & Dohme LLC
$49
Myriad Genetic Laboratories, Inc.
$45
UROGEN PHARMA, INC.
$38
PROCEPT BioRobotics Corporation
$29
Teleflex LLC
$26
COLOPLAST CORP
$24
Endo Pharmaceuticals Inc.
$21
Tolmar, Inc.
$20
Olympus America Inc.
$19
KOELIS Inc.
$18
PROGENICS PHARMACEUTICALS, INC.
$18
PFIZER INC.
$15
Axonics, Inc.
$14
Top 3 companies account for 38.5% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$5,200
Janssen Biotech, Inc.
$870
Endo Pharmaceuticals Inc.
$404
Astellas Pharma US Inc
$244
Merck Sharp & Dohme LLC
$174
Ferring Pharmaceuticals Inc.
$157
Becton, Dickinson and Company
$150
Sumitomo Pharma America, Inc.
$141
Teleflex LLC
$141
ABBVIE INC.
$141
Boston Scientific Corporation
$137
PFIZER INC.
$136
Bayer HealthCare Pharmaceuticals Inc.
$114
Merck Sharp & Dohme Corporation
$99
BOSTON SCIENTIFIC CORPORATION
$96
COLOPLAST CORP
$78
Endo USA, Inc.
$74
Dendreon Pharmaceuticals LLC
$68
Olympus America Inc.
$62
UROVANT SCIENCES INC
$60
Tolmar, Inc.
$59
AbbVie Inc.
$55
Coloplast Corp
$47
Myriad Genetic Laboratories, Inc.
$45
PROCEPT BioRobotics Corporation
$43
Progenics Pharmaceuticals, Inc.
$41
UROGEN PHARMA, INC.
$38
AstraZeneca Pharmaceuticals LP
$36
UroGen Pharma, Inc.
$32
TOLMAR Pharmaceuticals, Inc.
$31
ConvaTec Inc.
$26
Bayer Healthcare Pharmaceuticals Inc.
$24
Palette Life Sciences, Inc.
$20
KOELIS Inc.
$18
PROGENICS PHARMACEUTICALS, INC.
$18
Blue Earth Diagnostics Limited
$17
Axonics, Inc.
$14
180 Medical, Inc.
$11
Top 3 companies account for 71.0% of all-time payments
Associated products mentioned in payments ›
AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · Axumin · Bard Urinary Drainage Bag · EDEX · ELIGARD · ERLEADA · GEMTESA · GENERAL BPH · GENERAL - ONCOLOGY · GentleCath · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LithoVue · Luja Coude · MYRBETRIQ · MYRISK · Myrbetriq · NATRELLE · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · PYLARIFY · REZUM · Soltive · SpaceOAR VUE System - 10mL · SpeediCath · Titan · Trinity · UROLIFT · UroLift System · Veozah · Virtue · XIAFLEX · XTANDI · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
15
Per 100K population
7.3
County median income
$63,091
Nearest hospital
THE PAVILION
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of IL peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Patel performed 323 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $9,120 from 38 companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other urology physicians in Champaign?
Dr. Patel's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Champaign
Browse urology physicians in Champaign ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
Allergan Inc. Payments to Doctors
See all physicians who received payments from Allergan Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology